Investing Profile

Shinichiro Fuse

Advisor
Partner/Managing Director at TPG
Cambridge, Massachusetts
Photo of Shinichiro Fuse, Partner at TPG Biotech

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Morgan Stanley Network
693 CONNECTIONS
TPG Network
77 CONNECTIONS
TPG Network
77 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
cb
TPG Biotech Partner
MPM BioImpact Managing Director
7
$60M
CompanyStageDateRound SizeTotal Raised
Ouro Medicines
Series AJan 2025$120M
$120M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA)), Brian Matesic (Norwest Venture Partners)
Sudo Biosciences
Series BFeb 2024$30M
Series BDec 2023$120M
$180M
Co-investors: Daniel Estes (Frazier Life Sciences), Christopher Gagliardi (Sanofi Ventures)
Santa Ana Bio
Series AFeb 2023$43M
$170M
Co-investors: Sherry Chao (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Brendan Bulik-Sullivan (GV (Google Ventures)), Peter Emtage (Versant Ventures), Christine Borowski (Access Industries), Jerel Davis (Versant Ventures)
Orna Therapeutics
Series AFeb 2021$80M
SeedJan 2020$20M
$320M
Co-investors: Ansbert Gadicke (MPM Capital), Sakae Asanuma (Hotmail)
Triplet Therapeutics
Series ADec 2019$49M
$49M
Co-investors: Jean-François Formela (Atlas Venture)
Summer Associate Morgan StanleyPresent
Associate Consultant Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Consultant Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Consultant Clarion HealthcarePresent
Associate PureTech HealthPresent
Associate PureTech VenturesPresent
Senior Consultant inVentiv HealthPresent
Engagement Manager inVentiv HealthPresent
Engagement Manager inVentiv Health - Campbell Alliance, Management ConsultingPresent
Senior Manager, Business Development Bluebird BioPresent
Director, Business Development Bluebird BioPresent
Principal MPM BioImpactPresent
Founding/Interim Senior Vice President, Business Development ElevateBioPresent
Advisor ElevateBioPresent
Board Member Orna TherapeuticsPresent
Interim CEO / Board Member Orna TherapeuticsPresent
Interim CEO / Board Member Orna Therapeutics, Inc.Present
Partner TPGPresent
Partner/Managing Director TPGPresent
Managing Director MPM BioImpact2018 - 2021
Keio University B.E. Applied Chemistry
The University of Tokyo M.S. Medical Sciences
Geisel School of Medicine at Dartmouth Ph.D. Microbiology and Immunology
Sign in with Google →
Sign in with Google →